Aclaris Therapeutics Inc (ACRS) — Working Capital to Net Assets Ratio
Aclaris Therapeutics Inc (ACRS) has a Working Capital to Net Assets ratio of 62.4% as of September 2025. Working capital of $74.96 Million (current assets of $100.59 Million minus current liabilities of $25.63 Million) is measured against net assets of $120.10 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See Aclaris Therapeutics Inc (ACRS) flexibility index to measure the company's free cash flow as a share of total liabilities.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Aclaris Therapeutics Inc Working Capital to Net Assets (2013–2024)
This chart shows how Aclaris Therapeutics Inc's Working Capital to Net Assets ratio has evolved across 12 annual periods from 2013 to 2024. As of September 2025, the ratio stands at 62.4%, reflecting working capital of $74.96 Million against net assets of $120.10 Million USD. See Aclaris Therapeutics Inc (ACRS) liquidity interval to measure how many days the company can operate on defensive assets alone.
Annual Working Capital to Net Assets for Aclaris Therapeutics Inc (2013–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for Aclaris Therapeutics Inc from 2013 to 2024, covering 12 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see market cap of Aclaris Therapeutics Inc.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 60.7% | $94.36 Million | $155.55 Million | $125.95 Million | $31.60 Million | ▼ -1.6 pp |
| 2023 | 62.3% | $97.90 Million | $157.18 Million | $128.86 Million | $30.95 Million | ▼ -43.8 pp |
| 2022 | 106.1% | $209.61 Million | $197.62 Million | $231.55 Million | $21.94 Million | ▲ +13.8 pp |
| 2021 | 92.3% | $182.10 Million | $197.34 Million | $205.03 Million | $22.93 Million | ▼ -20.9 pp |
| 2020 | 113.2% | $42.62 Million | $37.65 Million | $57.49 Million | $14.87 Million | ▲ +25.4 pp |
| 2019 | 87.8% | $61.37 Million | $69.91 Million | $83.80 Million | $22.43 Million | ▲ +17.1 pp |
| 2018 | 70.7% | $152.16 Million | $215.12 Million | $179.50 Million | $27.34 Million | ▼ -16.3 pp |
| 2017 | 87.1% | $196.09 Million | $225.26 Million | $208.85 Million | $12.76 Million | ▼ -12.0 pp |
| 2016 | 99.1% | $167.91 Million | $169.49 Million | $174.13 Million | $6.22 Million | ▲ +1.3 pp |
| 2015 | 97.8% | $90.48 Million | $92.52 Million | $92.04 Million | $1.55 Million | ▲ +169.5 pp |
| 2014 | -71.7% | $14.88 Million | $-20.75 Million | $16.33 Million | $1.45 Million | ▲ +70.4 pp |
| 2013 | -142.1% | $13.02 Million | $-9.16 Million | $13.39 Million | $367.00K | — |